Cardiometabolic Guidelines: Cardiovascular Risk Assessment and Management in Patients with Dysglycemia
Mohamed Hassanein, Wael Almahmeed(Abu Dhabi Health Services), Muhammad H. Farooqi(Dubai Health Authority), Alaaeldin Bashier(Dubai Hospital), Rabih Hijazi, Sami Kenz, Khadija Hafidh, Francesco Cosentino(Linköping University), Mohamed Suliman, Hani Sabbour, Hassan El Tamimi, Mohammed Farghali, Abdul Jabbar, Hosam Zaky, Abdullah Shehab, Fatheya Al Awadi, Seema Elkhider Nour, Juma Al Kaabi(United Arab Emirates University), Hussein Heshmat, Salah Abusnana(University of Sharjah), Jeff Shook, Bachar Afandi(Tawam Hospital)
Cited by 9
Related Papers
Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends
|Journal of Epidemiology and Global Health|2019|3.1k
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
|European Heart Journal|2013|1.4k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2018|716
Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation
|European Journal of Preventive Cardiology|2022|334